Publications by authors named "Anthony Edmonds"

Claim this Profile
S
Structure-Guided Design of ISOX-DUAL-Based Degraders Targeting BRD4 and CBP/EP300: A Case of Degrader Collapse.
Anthony K Edmonds, Dimitrios-Ilias Balourdas, Graham P Marsh, Robert Felix, Bradley Brasher

J Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development.
Mark S Cooper, Mark C Norley, Simon Armitage, Joel O Cresser-Brown, Anthony K Edmonds

Org Biomol Chem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Convenient, Rapid, Conventional Heating Route to MIDA Boronates.
Andrew McGown, Anthony K Edmonds, Daniel Guest, Verity L Holmes, Chris Dadswell

Molecules· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scale-up and optimization of the synthesis of dual CBP/BRD4 inhibitor ISOX-DUAL.
Anthony K Edmonds, Catherine S Oakes, Storm Hassell-Hart, Didier Bruyère, Graham J Tizzard

Org Biomol Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological Correlates of Protection against a GII.4 Norovirus.
Robert L Atmar, David I Bernstein, G Marshall Lyon, John J Treanor, Mohamed S Al-Ibrahim, Anthony Edmonds

Clin Vaccine Immunol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
Kristof Chwalisz, Lois Larsen, Cynthia Mattia-Goldberg, Anthony Edmonds, Walter Elger

Fertil Steril· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis